Recent advances in AIE-based platforms for cancer immunotherapy

Ziyi Chen,Xueping Li,Qian Liu,Wen Li,Tianjiao Wang,Dan Ding
DOI: https://doi.org/10.1016/j.jconrel.2024.09.041
IF: 11.467
2024-10-06
Journal of Controlled Release
Abstract:Aggregation-induced emission luminogens (AIEgens) possess the unique property of enhanced fluorescence and photostability in aggregated states, making them exceptional materials for the convergence of imaging and phototherapy. With their inherent advantages, AIEgens are propelling the field of nanomedicine into a vibrant frontier in the phototheranostics of a spectrum of diseases, particularly in the realm of cancer immunotherapy. AIEgens-based therapeutics enhance the cancer immune response through a variety of approaches, including real-time image-guided precise therapy, induction of programmed cell death, metabolic reprogramming, and modulation of the tumor microenvironment. Additionally, they contribute to the synergistic effect of immune checkpoint inhibition, a pivotal aspect of modern cancer immunotherapy strategies. This review offers a comprehensive overview of the integration of AIEgens in nanomedicine and their role in immune adaptation, highlighting the advantages, basic action mechanisms, and recent advancement of AIEgens as promising therapeutic platform for cancer immunotherapy.
pharmacology & pharmacy,chemistry, multidisciplinary
What problem does this paper attempt to address?